Early differentiation between dengue and septic shock by comparison of admission hemodynamic, clinical, and laboratory variables: A pilot study

Pediatric Emergency Care

Volumn 23, Issue 6, 2007, Pages 368-375

  Ranjit, Suchitra ^a   Kissoon, Niranjan ^b   Gandhi, Deepika ^a   Dayal, Anjul ^a   Rajeshwari, N ^a   Kamath, Shrishu R ^a  

^a APOLLO HOSPITALS   (India)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Dengue shock; Outcomes; Resuscitation; Septic shock; Steroids; Treatment

Indexed keywords

CATECHOLAMINE; STEROID; VASOACTIVE AGENT;

AGE DISTRIBUTION; ARTICLE; ARTIFICIAL VENTILATION; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; DENGUE; DIFFERENTIAL DIAGNOSIS; EMERGENCY CARE; FEMALE; FLUID RESUSCITATION; HEART RATE; HEMATOCRIT; HEMODYNAMIC MONITORING; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE; LABORATORY TEST; MALE; MEDICAL RECORD; MORTALITY; PULSE PRESSURE; RETROSPECTIVE STUDY; SCORING SYSTEM; SEPTIC SHOCK; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; THROMBOCYTE COUNT; TREATMENT OUTCOME;

BLOOD PRESSURE; BODY TEMPERATURE; CHILD; CHILD, PRESCHOOL; DENGUE; DIAGNOSIS, DIFFERENTIAL; EARLY DIAGNOSIS; EMERGENCY MEDICINE; FEMALE; FLUID THERAPY; HEART RATE; HUMANS; INFANT; LEUKOCYTE COUNT; MALE; PEDIATRICS; PILOT PROJECTS; REFERENCE VALUES; RESPIRATION; RETROSPECTIVE STUDIES; SHOCK, SEPTIC; TREATMENT OUTCOME;

EID: 34250715964     PISSN: 07495161     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pec.0000278403.22450.a2     Document Type: Article

References (38)

1. Gibbons RV, Vaughn DW. Dengue: an escalating problem. BMJ. 2002;324:1563-1566.
2. Carcillo JA, Fields AI, Task Force Committee Members. Clinical practice variables for hemodynamic support of pediatric and neonatal patients in septic shock. Crit Care Med. 2002;30:1365-1378.
3. Dellinger RP, Carlet JM, Masur H, et al. Surviving Sepsis Campaign Management Guidelines Committee. Surviving sepsis campaign guidelines for management of severe sepsis and septic shock. Crit Care Med. 2004;32:858-873.
4. Goldstein B, Giroir B, Randolph A, International Consensus Conference on Pediatric Sepsis. International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med. 2005;6:2-8.
5. Zaritsky AL, Nadkarni VM, Hickey RW, et al., eds. Pediatric Advanced Life Support Provider Manual. 2002 ed. Dallas, TX: American Heart Association; 2002.
6. Dengue Haemorrhagic Fever: Diagnosis, Treatment, Prevention and Control. Second Edition. Geneva, WHO, 1997. Available at: http://www.who.int/csr/ resources/publications/dengue/Denguepublication/en/. Accessed March 2, 2006.
7. Prevention and Control of Dengue and Dengue Haemorrhagic Fever. Comprehensive Guidelines. New Delhi, WHO Regional Publication, SEARO NO 29, 1999. Available at: http://w3.whosea.org/EN/Section10/Section332/ Section521_2464.htm. Accessed March 2, 2006.
8. Ranjit S, Kissoon N, Jayakumar I. Aggressive management of dengue shock syndrome may decrease mortality rate: a suggested protocol. Pediatr Crit Care Med. 2005;6(4):412-419.
9. Cuzzubbo AJ, Vaughn DW, Nisalak A, et al. Comparison of PanBio Dengue Duo IgM and IgG capture ELISA and venture technologies. J Clin Virol. 2000;16(2):135-144.
10. Kalayanarooj S, Chansiriwongs V, Nimmannitya S. Dengue patients at the children's hospital, Bangkok: 1995-1999 Review. Available at: http://w3.whosea.org/LinkFiles/Dengue_Bulletin_Volume_26_Chap05.pdf. Accessed February 15, 2006.
11. Bone RC, Sprung CL, Sibbald WJ. Definitions for sepsis and organ failure. Crit Care Med. 1992;20:724-726.
12. Parker MM, Hazelzet JA, Carcillo JA. Pediatric considerations. Crit Care Med. 2004;32:591-594.
13. Pollack MM, Patel KM, Ruttimann UE. PRISM III: an updated Pediatric Risk of Mortality score. Crit Care Med. 1996;24(5):743-752.
14. Wills BA, Nguyen MD, Ha TL, et al. Comparison of three fluid solutions for resuscitation in dengue shock syndrome. N Engl J Med. 2005;9(353):877-889.
15. Molyneux EM, Maitland K. Intravenous fluids - getting the balance right. N Engl J Med. 2005;9(353):941-944.
16. Bethell DB, Gamble J, Pham PL, et al. Noninvasive measurement of microvascular leakage in patients with dengue hemorrhagic fever. Clin Infect Dis. 2001;32:243-253.
17. Tassniyom S, Vasanawathana S, Chirawatkul A, et al. Failure of highdose methylprednisolone in established dengue shock syndrome: a placebo-controlled, double-blind study. Pediatrics. 1993;92:111-115.
18. Booy R, Habibi P, Nadel S, et al. Reduction in case fatality rate from meningococcal disease associated with improved healthcare delivery. Arch Dis Child. 2001;85:386-390.
19. Angus DC, Linde-Zwirble WT, Lidicker J, et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001;29(7):1303-1310.
20. Kutko MC, Calarco MP, Flaherty MB. Mortality rates in pediatric septic shock with and without multiple organ system failure. Pediatr Crit Care Med. 2003;4(3):333-337.
21. Pizarro CF, Troster EJ, Damiani D, et al. Absolute and relative adrenal insufficiency in children with septic shock. Crit Care Med. 2005;33(4):855-859.
22. Shah I, Deshpande GC, Tardeja PN. Outbreak of dengue in Mumbai and predictive markers for dengue shock syndrome. J Trop Pediatr. 2004;50(5):301-305.
23. Sideridis K, Canario D, Cunha BA. Dengue fever: diagnostic importance of a camelback fever pattern. Heart Lung. 2003;32(6):414-418.
24. Singh R, Uttam R, Khilnani P. Viral hemorrhagic fever: management in pediatric intensive care unit. Indian J Crit Care Med. 2002;6(2):103-120.
25. Gubler DJ. Dengue and dengue hemorrhagic fever. Clin Microbiol Rev. 1998;3:480-496.
26. Dengue, Dengue Haemorrhagic Fever and Dengue Shock Syndrome in the Context of the Integrated Management of Childhood Illness. Available at: http://www.who.int/child-adolescent-health/publications/pubCNHhtm. Accessed March 12, 2006.
27. Ceneviva G, Paschall J, Maffei F, et al. Hemodynamic support in fluid-refractory pediatric septic shock. Pediatrics. 1998;102:391.
28. Silver P. Inodilator therapy in pediatric septic shock. Pediatr Crit Care Med. 2001;2(1):102-104.
29. Khongphatthanayothin A, Suesaowalak M, Muangmingsook S, et al. Hemodynamic profiles of patients with dengue hemorrhagic fever during toxic stage: an echocardiographic study. Intensive Care Med. 2003;29:570-574.
30. Welch SB, Nadel S. Treatment of meningococcal infection. Arch Dis Child. 2003;88:608-614.
31. Hatherill M, Tibby SM, Hilliard T, et al. Adrenal insufficiency in septic shock. Arch Dis Child. 1999;80:51-55.
32. Otieno H, Were E, Ahmed I, et al. Are bedside features of shock reproducible between different observers? Arch Dis Child. 2004;89:977-979.
33. Pamba A, Maitland K. Capillary refill: prognostic value in Kenyan children. Arch Dis Child. 2004;89:950-955.
34. Gomber S, Ramachandran VG, Kumar S, et al. Hematological observations as diagnostic markers in dengue hemorrhagic fever - a reappraisal. Indian Pediatr. 2001;38:477-481.
35. Chua MN, Molanida R, de Guzman M, et al. Prothrombin time and partial thromboplastin time as a predictor of bleeding in patients with dengue hemorrhagic fever. Southeast Asian J Trop Med Public Health. 1993;24(suppl 1):141-143.
36. Pollack MM, Mink RB. Effect of blood transfusion on oxygen consumption in pediatric septic shock. Crit Care Med. 1990;18(10):1087-1091.
37. Deuren MV, Neeleman C, Van 't Hek LGFM, et al. A normal platelet count at admission in acute meningococcal disease does not exclude a fulminant course. Intensive Care Med. 1998;24(2):157-161.
38. Baines PB, Hart CA. Severe meningococcal disease in childhood. Br J Anaesth. 2003;90(1):72-83.